Company: ARTL
Filing Date: 2025-07-11
Form Type: S-1
Source: 0001640334-25-001190
Chunk: 32

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-07-11
Form: S-1
Chunk 32
---
uable pursuant to options held directly by Gregory R. Reyes M.D., Ph.D. exercisable within 60 days of June 30, 2025.                                                                                                             |
| (7) | Consists of 385 shares of Common Stock issuable pursuant to options held directly by Tamara A. Favorito exercisable within 60 days of June 30, 2025.                                                                                                                       |
| (8) | Includes 27,759 shares of Common Stock subject to options exercisable within 60 days of June 30, 2025.                                                                                                                                                                     |

| 21 |

<div align='center'>DESCRIPTION OF CAPITAL STOCK</div>

The following description summarizes certain terms of our capital stock and certain provisions of our certificate of incorporation and bylaws. This summary does not purport to be complete and is qualified in its entirety by the provisions of our certificate of incorporation and bylaws, copies of which are filed with the SEC as exhibits to the Registration Statement on Form S-1 of which this prospectus forms a part, and to the applicable provisions of Nevada law.

Authorized CapitalStock

Our authorized capital stock consists of 8,402,778 shares of capital stock, of which 8,333,333 shares are designated as common stock, $0.001 par value per share, and 69,445 shares are designated as preferred stock, $0.001 par value per share. As of March 31, 2025, there were 567,582 shares of Common Stock issued and outstanding held by approximately 165 holders of record of our Common Stock, and no outstanding shares of preferred stock.

Common Stock

The holders of our Common Stock (i) have equal ratable rights to dividends from funds legally available, therefore, when, as and if declared by our board of directors; (ii) are entitled to share in all of our assets available for distribution to holders of Common Stock upon liquidation, dissolution or winding up of our affairs; (iii) do not have preemptive, subscription or conversion rights and there are no redemption or sinking fund provisions or rights; and (iv) are entitled to one non-cumulative vote per share on all matters submitted to a vote of stockholders. The rights, preferences and privileges of the holders of our Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate in the future.

Preferred Stock

The Company has authorized 69,445 shares of preferred stock. There is